MODASAFE 300

Here is the HTML fragment of the MODASAFE 300 drug description, created in accordance with your requirements.

What is MODASAFE 300?

MODASAFE 300 is a modern drug belonging to the pharmacological group of psychostimulants and nootropic drugs, developed for the correction of pathological daytime sleepiness and increasing cognitive performance. The main active substance of the drug is modafinil, which is characterized by a unique mechanism of influence on the central nervous system, which significantly distinguishes it from classic amphetamine-type stimulants. The manufacturer of MODASAFE 300 is the pharmaceutical company Orange City, which specializes in the production of high-quality generics and innovative formulas. The drug is presented in the form of tablets for oral administration with a dosage of 300 mg, which allows providing a long and stable therapeutic effect throughout the day. Thanks to a balanced composition and a high safety profile, MODASAFE 300 is widely used in neurological and psychiatric practice to improve the quality of life of patients with sleep-wake cycle disorders.

The pharmacological action of MODASAFE 300 is based on the ability of modafinil to selectively activate certain areas of the brain responsible for maintaining a state of wakefulness, without excessive excitation of the peripheral nervous system. Unlike traditional psychostimulants, the drug does not cause severe euphoria, tremors, or sharp drops in blood pressure, which makes its use more comfortable for the patient. MODASAFE 300 helps to restore natural levels of activity in people suffering from narcolepsy, obstructive sleep apnea, or shift work sleep disorder. The therapeutic effect develops gradually, reaching a peak concentration in blood plasma 2–4 hours after administration, which ensures a smooth transition into the work process. The drug is dispensed by prescription, as it requires a preliminary examination and the exclusion of contraindications.

The manufacturer Orange City pays special attention to quality control at all stages of MODASAFE 300 production, which guarantees compliance with international GMP standards. Each tablet contains a precisely calibrated dose of the active substance, which avoids fluctuations in the therapeutic effect and minimizes the risk of adverse reactions. The drug belongs to the category of agents that increase mental and physical endurance, but is not a substitute for healthy sleep. MODASAFE 300 should be considered as an auxiliary tool for normalizing daytime functioning in patients with confirmed medical indications. Consultation with a physician is mandatory before starting therapy to assess the benefit-risk ratio for an individual patient.

What is MODASAFE 300 prescribed for?

The main indication for the use of MODASAFE 300 is narcolepsy — a chronic neurological disorder characterized by uncontrollable daytime sleep attacks. In such patients, the drug helps maintain a stable level of wakefulness, reducing the frequency and intensity of sudden falling asleep episodes. The therapeutic effect is achieved due to the impact on the hypothalamic centers that regulate the transition between sleep and wakefulness. MODASAFE 300 allows patients with narcolepsy to lead an active lifestyle, safely drive a car in permitted cases, and perform professional duties. It is important to understand that the drug does not cure the cause of the disease, but significantly improves its symptomatic control.

The second significant indication is obstructive sleep apnea syndrome, when night sleep is interrupted by frequent breathing pauses, which leads to chronic sleep deprivation and severe daytime sleepiness. MODASAFE 300 is prescribed as an adjunct to primary therapy, particularly to the use of CPAP machines, to improve daytime well-being. The drug helps compensate for the lack of restorative sleep, increasing focus of attention and speed of reactions. The remedy is also effective for shift work sleep disorder, when a person is forced to work at night or on an erratic schedule. In such cases, MODASAFE 300 promotes the adaptation of the body to changes in circadian rhythms and reduces the feeling of exhaustion.

In some clinical situations, MODASAFE 300 can be used off-label for the treatment of attention deficit hyperactivity disorder in adults, as well as to overcome severe asthenia in chronic diseases. The drug demonstrates a positive effect on cognitive functions, improving memory, learning ability, and executive brain functions. However, such use requires special caution and careful medical supervision, as clinical data regarding these indications are limited. MODASAFE 300 is not intended for self-medication or for use by healthy individuals to artificially boost productivity. Any prescription must be based on an established diagnosis and an assessment of individual risks.

Composition and active ingredients of MODASAFE 300

The active pharmaceutical ingredient of MODASAFE 300 is modafinil at a dosage of 300 mg per tablet. Modafinil is a synthetic compound belonging to the class of benzhydrylsulfinylacetamides, which exerts a pronounced wakefulness-promoting effect without a significant effect on the sympathetic nervous system. The mechanism of action of the substance is associated with an increase in extracellular dopamine concentration in the brain by blocking its reuptake. In addition, modafinil affects histamine, norepinephrine, and orexin receptors, providing a comprehensive stimulating effect on wakefulness centers. Such a multifactorial mechanism allows achieving a stable therapeutic effect without the development of pronounced tolerance.

Excipients of MODASAFE 300 are selected in such a way as to ensure optimal bioavailability of the active substance and tablet stability throughout the shelf life. The composition includes microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, and lactose monohydrate, which act as fillers, disintegrants, and binding agents. These substances do not have independent pharmacological activity, but ensure uniform release of modafinil in the gastrointestinal tract. The manufacturer Orange City uses highly purified raw materials, which minimizes the risk of allergic reactions and increases the tolerability of the drug. Patients with lactose intolerance should take into account its presence in the composition and consult a physician.

An important feature of the MODASAFE 300 composition is the absence of amphetamine-like compounds, which reduces the likelihood of developing addiction and withdrawal syndrome compared to classic psychostimulants. Modafinil has a lower abuse potential, although the risk of psychological dependence cannot be completely excluded. The therapeutic concentration of the drug in the blood is achieved gradually, which provides a gentle onset of action without a sharp "hit" to the nervous system. The elimination half-life of modafinil is about 12–15 hours, which allows taking the drug once a day. Metabolism occurs mainly in the liver with the participation of cytochrome P450 enzymes, which should be taken into account during combination therapy.

Dosage of MODASAFE 300

The standard recommended dose of MODASAFE 300 for adult patients is 300 mg once a day, preferably in the morning or 1–2 hours before the start of active work. Such a dosage regimen ensures maintaining an optimal concentration of the drug in the blood throughout the entire period of wakefulness. For patients with narcolepsy or obstructive sleep apnea syndrome, this dose is sufficient to control daytime sleepiness in most cases. In case of insufficient efficacy, the doctor may consider increasing the daily dose to 400 mg, but such a decision is made individually. Exceeding the maximum daily dose without medical supervision is strictly not recommended.

The duration of the treatment course with MODASAFE 300 is determined by the nature of the underlying disease and the patient's individual response to therapy. In chronic conditions such as narcolepsy, the drug can be prescribed for a long period with periodic evaluation of efficacy and safety. For patients with shift work sleep disorder, as-needed use is possible, but unsystematic intake should be avoided. Dose adjustment may be required in elderly patients, as well as in individuals with impaired liver or kidney function, as the elimination of the drug slows down in them. In such cases, the doctor may recommend reducing the dose to 100–200 mg per day.

MODASAFE 300 is not intended for use in children and adolescents under 18 years of age due to the lack of sufficient data on safety and efficacy in this age group. Patients starting therapy for the first time are recommended to start with the minimum effective dose to assess individual tolerability. If a dose of the drug was missed, the next dose should not be doubled, as this increases the risk of side effects. It is best to take the drug as soon as the patient remembers the omission, if there is a sufficient time interval left before the next intake. In case of doubt regarding the dosage regimen, it is necessary to consult a doctor or pharmacist for clarification.

How to take MODASAFE 300 correctly?

MODASAFE 300 should be taken orally with a sufficient amount of water, regardless of meals. However, it should be noted that consuming fatty foods can slow down the absorption of the drug and delay the onset of the therapeutic effect by 1–2 hours. To achieve a stable result, it is recommended to take the tablet at the same time every morning, which helps maintain a uniform concentration of the active substance in the body. The tablet should not be chewed, crushed, or divided, as this may break the integrity of the coating and alter the rate of modafinil release. It is important to adhere to the regularity of intake to avoid fluctuations in wakefulness levels during the day.

Taking MODASAFE 300 in the afternoon or evening can cause difficulty falling asleep and disruption of night sleep, so the drug should be taken no later than noon. For patients working night shifts, the doctor can adjust the intake time so that the peak of action falls during the period of active work. During therapy, it is recommended to maintain an adequate fluid intake and avoid excessive consumption of caffeinated drinks, as this can enhance the stimulating effect. If headaches, nausea, or anxiety occur at the beginning of treatment, you should inform your doctor for possible dose adjustment. Changing the intake regimen or discontinuing therapy on your own is not recommended.

Special attention should be paid to the body's individual response to MODASAFE 300, as sensitivity to psychostimulants can vary significantly among different people. In the first days of therapy, it is recommended to refrain from driving vehicles and performing potentially hazardous work until the condition stabilizes. If the patient forgot to take the drug in the morning, but remembered before lunch, a tablet can be taken, but in this case, some shift in bedtime is possible. If a dose is missed after lunch, it is better to skip the dose that day so as not to disturb night sleep. Before starting therapy, be sure to inform your doctor about all medications the patient takes on an ongoing basis.

Side effects of MODASAFE 300

The most common side effects of MODASAFE 300 are headache, nausea, decreased appetite, and feeling of anxiety, which usually occur at the start of therapy and disappear on their own within a few days. These reactions are associated with the body's adaptation to the stimulating effect of modafinil on the central nervous system. Patients may also note dry mouth, insomnia, dizziness, or palpitations, especially when exceeding the recommended dose. In most cases, these symptoms are mild to moderate and do not require discontinuation of the drug. To reduce discomfort, it is recommended to take the tablet after a light breakfast and avoid excessive caffeine consumption.

Uncommon adverse reactions of MODASAFE 300 include increased blood pressure, tachycardia, tremor, and emotional lability, which require medical attention. In rare cases, allergic reactions may be observed, including skin rash, itching, hives, or angioedema, requiring immediate discontinuation of the drug. Serious skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis are extremely rare, but life-threatening. Patients should seek immediate medical attention if a rash, blisters, sore throat, or fever occurs during therapy. Psychiatric disorders are also possible, including depression, hallucinations, or manic episodes, especially in patients with a psychiatric history.

Rare side effects of MODASAFE 300 may include liver disorders manifested by increased transaminase levels, jaundice, or pain in the right hypochondrium. In case of such symptoms, it is necessary to conduct a laboratory examination and decide on the appropriateness of continuing therapy. It is important to remember that the body's individual response to the drug can be unpredictable, so any unusual symptoms should be discussed with a doctor. Regular medical monitoring during treatment allows for timely identification of undesirable phenomena and adjustment of therapy. Patients with cardiovascular diseases are recommended periodic monitoring of blood pressure and an electrocardiogram.

Contraindications of MODASAFE 300

An absolute contraindication to the use of MODASAFE 300 is hypersensitivity to modafinil or any excipient of the drug in history. The drug is not prescribed to patients with severe anxiety, psychomotor agitation, or psychotic disorders, as the stimulating effect can exacerbate these conditions. MODASAFE 300 is also contraindicated in severe cardiovascular diseases, including uncontrolled arterial hypertension, recent myocardial infarction, unstable angina, and heart rhythm disorders. In patients with hypertrophic cardiomyopathy or mitral valve prolapse, the drug can be prescribed only after a thorough risk assessment.

MODASAFE 300 is not used in children and adolescents under 18 years of age, as the safety and efficacy of the drug in this population have not been established. Pregnancy is a contraindication to taking the drug, as modafinil can negatively affect fetal development, increasing the risk of congenital malformations. Women of reproductive age are recommended to use reliable methods of contraception during therapy and for two months after its completion. During breastfeeding, MODASAFE 300 is also contraindicated, as the active substance penetrates into breast milk. For patients with severe hepatic or renal impairment, the drug is prescribed with caution and in reduced doses.

Relative contraindications to the use of MODASAFE 300 are epilepsy and seizure disorders, as the drug can lower the seizure threshold. For patients with psychiatric conditions, including depression, bipolar disorder, or schizophrenia, the drug is prescribed only under careful observation. Persons with a tendency to substance abuse require special caution due to the potential risk of developing dependence. In elderly patients, MODASAFE 300 is prescribed taking into account a possible decline in liver and kidney function, which may require dose adjustment. Before starting therapy, be sure to inform your doctor about all existing diseases and medications taken.

Interaction of MODASAFE 300 with other drugs and alcohol

MODASAFE 300 can interact with a number of medicinal products, which requires mandatory notification of the doctor about all concomitant therapy. Modafinil is an inducer of cytochrome P450 enzymes, particularly CYP3A4, which can accelerate metabolism and reduce the effectiveness of hormonal contraceptives, antidepressants, anticoagulants, and certain antiepileptic drugs. Women taking oral contraceptives are recommended to use additional barrier methods of protection during therapy with MODASAFE 300 and for two months after its completion. Co-administration with other stimulants, including caffeine, may increase side effects on the cardiovascular system.

Consumption of alcohol during therapy with MODASAFE 300 is not recommended, as this can lead to unpredictable reactions from the central nervous system. Alcohol can both weaken the therapeutic effect of the drug and enhance its toxic effect on the liver. In addition, the combination of modafinil with alcohol increases the risk of dizziness, impaired coordination, and inappropriate behavior. Patients taking MODASAFE 300 should refrain from driving vehicles until they fully understand their individual response to the drug. The drug can affect the speed of psychomotor reactions, so activities requiring increased concentration require caution.

Where to buy MODASAFE 300 in Ukraine

MODASAFE 300 is available for purchase in pharmacy chains of Ukraine with a doctor's prescription, as the drug belongs to the prescription group of dispensing. The product can also be ordered through specialized online platforms delivering medicines, but it is important to make sure of the reliability of the supplier and the availability of appropriate licenses. The cost of the drug may vary depending on the region, pharmacy chain, and delivery conditions, so it is recommended to compare offers from several sources. MODASAFE 300 should be stored in a dry, dark place at a temperature not exceeding 25°C, out of the reach of children. The shelf life of the drug is 24 months from the date of manufacture, after which use is prohibited.

Before purchasing MODASAFE 300, be sure to consult a doctor regarding the appropriateness of using the drug in your specific case. Self-medication with psychostimulants can be dangerous to health and lead to the development of serious complications. The doctor will conduct the necessary examination, establish an accurate diagnosis, and determine the optimal dosage regimen. Remember that the body's individual response to the drug may vary, so the first days of therapy require special attention to well-being. MODASAFE 300 is an effective tool for correcting pathological daytime sleepiness only if used responsibly and under control.